So you canopy is a overpriced investment?Ever looked at GWPH pharmaceuticals? Q4 reporting period they had a revenue of just over 2 million, or 12.93 million per year atm. There market cap is currently 2.6 Billion. And there share price is $113 US per share. And the only thing that they sell is CBD gel caps. When CGC Q3 financials come out, I would anticipate a revenue of around 25 million. So annual of 100MILLION. ONLY WITH MEDICAL. So do the math on potential. 9.82 x 7.73 = $76.79US per share if you increase GWPH revenue to equal that of WEED'S revenue. Underpriced? I think so. And that's not even talking or looking at recreational. Those who take risks in newly developing markets become millionaires or multimillionaires. Let the " smart money " buy in when the annoucement that the bill has passed into law. By then they can pay 20 or 30$ minimum and get a tiny position instead of a nice big fat positon they could right now.